• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
WELLlife

WELLlife: COVID-19/Flu Test Sale Black Friday and Cyber Monday deals on home test kits

Stock up your family's medicine cabinet this Black Friday and Cyber Monday. WELLlife, a leading innovator in medical diagnostic and testing solutions, is increasing accessibility to respiratory illness testing in preparation for the year-end holidays. Between Nov. 24 to Dec. 2,

Authorized by the United States Food and Drug Administration (FDA) under Emergency Use Authorization (EUA), the WELLlife Home Test can be easily conducted at home. It's available without a prescription online and in stores.

"As we head into the holiday season, a simple antigen test before meeting family or friends can make a world of difference," said Elaine Zhang, Vice President of Strategic Marketing from Wondfo USA. "Testing isn't just about personal peace of mind; it's a responsibility to those around us—especially seniors, young children, and others who may be more vulnerable. By identifying cases early, we can curb the spread and ensure that our gatherings are filled with warmth and safety."

Test for flu and COVID at home before celebrating:

Winter holidays are best spent with family and friends, but it's important to help keep them safe from the flu—especially children and those with weakened immune systems.

In the past, testing for influenza was available only through healthcare professionals in clinical settings, where long waits during peak flu season could delay diagnosis and treatment.

WELLlife's home test now closes this gap by offering detection of both influenza strains (A and B) alongside SARS-CoV-2 in just 10 minutes. Unlike most rapid tests that focus only on COVID-19, WELLlife's product adds FLU testing for greater convenience. It eliminates the need to visit healthcare facilities, lowering the risk of spreading these viruses in public and helping people start recovery sooner.

A trusted choice for dependable results:

The WELLlife home test provides accurate with a single nasal swab in just 10 minutes.It offers industry-leading accuracy, which was clinically proven to exceed FDA's criteria.

Easy testing at home:

Avoid the stress of scheduling doctor's appointments or visiting the clinic. The WELLlife home test is easy to use for nearly everyone, including the elderly and parents with young children. With clear, simple instructions and non-intrusive procedures, the test can be easily conducted at home. The results are clearly displayed in the large viewing window on the testing panel.

Backed by quality:

With 15 years of experience in the development and manufacturing of medical diagnostic products, WELLlife applies rigorous quality standards across its entire supply chain. Unlike many competitors, WELLlife manages the production of its test kits. This ensures consistent quality and supply reliability, even during periods of high demand.



!

Nevro's HFX iQ™

Nevro's HFX iQ™ Spinal Cord Stimulation with AI earns CE Mark, expanding global reach

Nevro Corp. a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has received CE Mark Certification in Europe for its HFX iQ™ spinal cord stimulation (SCS) system. The CE marking allows Nevro to market HFX iQ in all countries that recognize this certification.

Read more →
TB Alliance

TB Alliance participates in Indonesia's high-level meeting on tuberculosis

TB Alliance is honored to join today's High-Level Meeting hosted by the Indonesian Ministry of Health. Leaders and experts in tuberculosis (TB) have convened to discuss strategies, innovations, and achievements in the global fight to end TB. The full-day session will bring together a distinguished group of global stakeholders dedicated to addressing and eliminating the TB pandemic.

Read more →
symmetric dimethylarginine

Chung-Ang University creates a non-invasive biosensor for early kidney disease detection

Traditionally, kidney health has been monitored by measuring blood creatinine levels, which indicate muscle breakdown. High creatinine levels can suggest that the kidneys are not filtering waste efficiently. However, creatinine levels can be affected by a person's muscle mass and only rise significantly after more than 75% of kidney function is lost.

Read more →
Dr. Philippe Marambaud

Feinstein Institutes Research Shows Cancer Drugs Could Help With Vascular Disease

A drug commonly used to treat breast cancer might be able to help people living with hereditary hemorrhagic telangiectasia (HHT) – a rare genetic bleeding condition that causes enlargements and tangles of veins and arteries, as well as other malformations of the blood vessels – according to new research from The Feinstein Institutes for Medical Research.

Read more →
BioRise in chamber version 1

Akadeum Life Sciences will showcase advancements for cell therapy workflows at the 2024 Cell and Gene Meeting on the Mesa

Akadeum Life Sciences is excited to announce its participation Mesa, a globally recognized program held at the iconic Arizona Biltmore. This premier program brings together senior executives and key decision-makers from the cell and gene therapy industry to engage in critical discussions, presentations, and partnering sessions aimed at advancing the next generation of therapeutics.

Read more →